- Home
- BWMX vs MYGN Comparison
BWMX vs MYGN Comparison
Compare BWMX & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMX
- MYGN
- Stock Information
- Founded
- BWMX 1995
- MYGN 1991
- Country
- BWMX Mexico
- MYGN United States
- Employees
- BWMX N/A
- MYGN N/A
- Industry
- BWMX Catalog/Specialty Distribution
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BWMX Consumer Discretionary
- MYGN Health Care
- Exchange
- BWMX Nasdaq
- MYGN Nasdaq
- Market Cap
- BWMX 488.8M
- MYGN 423.1M
- IPO Year
- BWMX N/A
- MYGN 1995
- Fundamental
- Price
- BWMX $14.07
- MYGN $3.91
- Analyst Decision
- BWMX Strong Buy
- MYGN Hold
- Analyst Count
- BWMX 1
- MYGN 15
- Target Price
- BWMX $22.50
- MYGN $15.14
- AVG Volume (30 Days)
- BWMX 91.3K
- MYGN 1.3M
- Earning Date
- BWMX 07-24-2025
- MYGN 08-12-2025
- Dividend Yield
- BWMX 10.81%
- MYGN N/A
- EPS Growth
- BWMX N/A
- MYGN N/A
- EPS
- BWMX 0.84
- MYGN N/A
- Revenue
- BWMX $751,432,052.00
- MYGN $831,300,000.00
- Revenue This Year
- BWMX $6.54
- MYGN N/A
- Revenue Next Year
- BWMX $6.09
- MYGN $6.64
- P/E Ratio
- BWMX $16.50
- MYGN N/A
- Revenue Growth
- BWMX 4.83
- MYGN 7.38
- 52 Week Low
- BWMX $7.00
- MYGN $3.76
- 52 Week High
- BWMX $14.73
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- BWMX 77.23
- MYGN 30.03
- Support Level
- BWMX $9.15
- MYGN $3.76
- Resistance Level
- BWMX $13.39
- MYGN $4.83
- Average True Range (ATR)
- BWMX 0.71
- MYGN 0.24
- MACD
- BWMX 0.38
- MYGN -0.09
- Stochastic Oscillator
- BWMX 90.57
- MYGN 8.33
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.